Introduction
Hepatocellular carcinoma (HCC) is the fourth most common malignant cancer, with more than one million patients affected worldwide per year [1, 2] . Large-scale gene expression profiling has provided important insights into the biology of HCC with regard to classification, etiology, survival prediction and identification of signaling pathways that may possibly serve as therapeutic targets [3] [4] [5] [6] [7] . Cholangiolar carcinoma (CC) represents about 10-20% of all hepatobiliary tumors [8] with strong geographic variations [9] . Clinical outcome is still poor despite new therapeutic approaches similar to HCC [10] .
Cell lines derived from HCC and CC surgical specimens serve as in vitro systems to identify candidate genes of carcinogenesis and the effect of drugs and toxins on liver-derived cells. These tumor cells serve also as dynamic systems which can be altered, e.g. by gene silencing. Moreover, fixation artifacts, which are a major problem in formalin-fixed and paraffin-embedded specimens for genetic analyses, are not an issue in cell lines. This can also be said for the admixture of nonneoplastic cells typically seen in surgical tumor specimens.
Despite their frequent use for research purposes, it is not clear whether these cell lines are representative and mirror the mechanisms responsible for malignancy in vivo. Indeed, to the best of our knowledge, no systematic molecular cytogenetic analysis has yet been performed for hepatocytic and cholangiolar tumor cell lines in regard to this problem; it is therefore not clear whether or not cell lines in their cytogenetic findings are comparable to surgical tumor specimens grown in vivo. It is also not clear if there are mandatory chromosomal imbalances for maintaining tumor cells.
To answer these questions we focused on the detection of chromosomal aberrations in HCC-and CC-derived cell lines using an array-based high density comparative genomic hybridization (aCGH) system. The results were compared with regard to the hepatocellular and cholangiocellular origin of tumor cells analyzed, as well as to the findings reported in the literature for surgical tumor specimens.
Material and Methods
Cell Lines HCC cell lines Hep3b and HepG2 were supplied by DSMZ (Braunschweig, Germany). Carcinoma cell lines of cholangiolar differentiation EGI-1 and TFK-1 were also supplied by DSMZ, whereas Mz-Cha-1 came from ATCC (Manassas, Va., USA). Two of these cell lines (MzChA-1 and TFK-1) were available also as tumor specimens grown in a mouse model (nude mice; NMRI nu/ nu). Cell lines HLF, HLE and Huh7 were kindly provided by Prof. Huh (Dept. of Cell Biology, Okayama University).
Cell Cultures
Tumor cell lines were incubated in DMEM with 10% fetal calf serum supplemented with glutamine and penicillin/streptomycin at 37 ° C in a 5% CO 2 atmosphere in 25-cm 2 tissue flasks (Oxoid TPP 90025, Oxoid, Pratteln, Switzerland).
Arrays for Comparative Genomic Hybridization
aCGH was performed using a high-density array system with 244,000 oligonucleotides on a chip (Cat. No. G4411B, Agilent, Waldbronn, Germany), covering the complete genome in an average of approximately 5-13 kB. DNA was isolated using the QIAamp DNA Mini kit, (Qiagen Cat. No. 51304), following the supplier's instructions for cultured cells.
Labeling and hybridization were also done as described by the supplier. As a reference, DNA of a female donor was taken (Cat. No. G1521, Promega, Mannheim, Germany). Hybridization was performed for 40 h at 65 ° C in a hybridization oven (Agilent G2545A).
Validation of aCGH Results by Fluorescence in situ Hybridization
Fluorescence in situ hybridization (FISH) was performed as described earlier in detail [11] . For all cell lines, 5 centromere-and 10 locus-specific probes were applied (all were supplied by Abbott/Vysis, Baar, Switzerland; see table 2). Locus-specific probes were used to directly confirm the aCGH results. Centromere-specific probes were used to determine the polyploidy of tumor cells as this cannot be done by aCGH, due to technical reasons.
Data Analysis
Array images were acquired using a laser scanner (Agilent Scanner System 2605, Agilent). Hybridization spots on a slide were normalized with feature extraction software (version 9.5.3.1.) and processed as described below.
Data were imported to the Genomic Workbench software program version 5.0.14 (Agilent). The search for common aberrations was performed using the ADM1 algorithm based on a t test. The other parameters were set as follows: threshold 6 (the number of spots necessary to indicate an aberration), applied genome hg18 (data set of annotations available at the time of analyses), p-value threshold of 0.05, overlap 0.9 (indicates covering of the complete genome; more information provided on the supplier's website). Aberrations were searched with a resolution of up to 10 kB; those found for less than 3 probes only were not regarded for further analysis. ( table 2 ) . By applying centromere-specific probes we found a polyploidy, indicated by a mean of 1 2.50 signals/nucleus, in 3 of 5 HCC cell lines, i.e. HLE, Huh7 and Hep3b.
Results

Overall Findings in HCC Cell Lines
We compared these aberrations found by aCGH with those obtained in surgical specimens and reported by Moinzadeh et al. [12] . Overall, there was a clear agreement between imbalances seen in these specimens and in the cell lines of our study; however, the percentage of cases of specific aberration differed. Whereas in the surgical specimens the number of affected cases was maximally about 55%, aberrations were seen in part in all our samples ( table 3 ) .
Overall Findings in CC Cell Lines
Gains were detectable in all 3 cell lines for chromosomes 1, 5, 8 and 17, respectively. Losses in all 3 cell lines were seen for parts of chromosomes 3, 6 and 8, respectively. The shortest aberration spanned 10 kB (2 spots) and the longest covered 78,716,614 kB (6,078 spots) as listed in table 1 .
These results were confirmed by FISH, using the locus-specific probes in 28 of 30 analyses. Polyploidy was seen in 2 of 3 cell lines (EGI1 and MzCha-1).
Our data were compared to those given for surgical tumor specimens in the progenetix database analyzed by conventional and/or aCGH. In this database, the most frequent aberrations occurring in at least 30% of cases were losses for 1p and 6q, and gains for 8q, 17q and 20q, respectively. In our CC cell lines we were able to confirm gains for chromosomes 8q and 17q, and a loss of 6q, respectively ( table 3 ) .
Based on the two main tasks of our study, we separated these findings into 2 main groups.
(1) Aberrations of hepatocellular or cholangiocellular origin:
(a) detectable in all HCC cell lines but in none of the CC cell lines (b) detectable in all CC cell lines but in none of the HCC cell lines (c) occurring in all HCC and CC cell lines (2) Aberrations occurring in all HCC or CC cell lines but rarely reported in surgical tumor specimens ( ! 5%).
Within these groups we found chromosomal imbalances as follows:
Group 1a
In all HCC cell lines, gains of chromosomal material were seen for the long arm of chromosome 1 including bands q21, q22, q23.2-24.1, q32.2, q42.12 and q42.2, respectively ( fig. 1 ) . In addition, 1p demonstrated a gain for the region p36.33.
In 13q, we found chromosome bands q14.11-q31.3 to be a commonly lost region in all HCC cell lines ( fig. 3 ) . Surprisingly, none of the CC cell lines demonstrated this aberration. As a loss of 13q is reported to be correlated to a low differentiation of carcinoma cells, we looked for the Spe cimens were from [12] and the Progenetix data base, with an incidence of at least 20%. These aberrations were also seen in the cell lines of our study but with a higher percentage of affected samples. 
Group 1b
Chromosomal imbalances seen only in CC cell lines but in none of the HCC cell lines were not detectable. However, for chromosome 8, a combination of imbalances occurred in CC cell lines only. There was a gain of 8q spanning 8q13-qter for all 3 samples ( fig. 2 ). This gain was nearly complete loss or gain of the chromosome. In cell line Hep3b, a loss of major parts of the chromosomes was seen, interrupted by some areas of gain in the long arm. There was, however, no consistent loss of 8p in comparison to 8q.
Group 1c
The only chromosomal aberration found in both kinds of cell lines and in all samples was 17q+ spanning bands q22-qter ( fig. 4 ) . In HCC cell lines, as seen for larger parts of 17p, the more proximal chromosomal bands up to q12 were also gained. However, gain of 17p was not complete, but interrupted for regions p11 and p13-qter in 4 samples. In contrast, in CC, a loss of 17p was seen in 2 samples (EZI-1, MzCha-1). For TFK-1, a loss of 17p was not found (confirmed by FISH); however, there was also an imbalance in the sense of a relative loss of 17p in comparison to 17q.
Group 2
Within this group we collected chromosomal imbalances that were seen in all HCC or CC cell lines, but reported in less than 5% of surgical tumor specimens in the literature. By this criterion, partial or complete gains of 11p, 12p, 14q, 16p, 16q, 21q and 22q were included in this group.
Discussion
Cell lines are an important system for evaluating pharmacological and toxicological effects in humans [13] . They often also reveal the basic mechanisms of tumor growth and development and are a frequently used source for research purposes [14] . Moreover, they represent a pure population of tumor cells without an admixture of inflammatory cells or fibroblasts, for example, typically seen as a desmoplastic reaction in solid tumors. This decreases the threshold for the detection of tumor-specific terations such as genomic imbalances; however, cell lines of solid tumors are difficult to establish. This observation is still poorly understood and it is questionable whether there is a bias for successfully maintaining such cells in vitro. We therefore looked for chromosomal imbalances that part HCC cells from CC cells and/or for aberrations Chromosomal imbalances parting HCC cell lines from CC cell lines were taken together in group 1. Here, we found gains of 1q at first. This was expected since these aberrations are reported most frequently in surgical tumor specimens with 57% of cases affected by gains of 1q21-2 as shown in a meta-analysis of 785 samples using conventional CGH analysis [12] , and in 90% of samples using aCGH [15] . Similar reports have been made for the regions more distal on 1q including q23, q32 and q42, respectively. We therefore assume these aberrations to be a basic event in carcinogenesis in surgical tumor samples as well as in cell lines of hepatocellular origin.
A further aberration seen in all HCC cell lines but in none of the CC cell lines was the loss of 13q14-q31.1. Losses of 13q have been reported in 27% of surgical specimens of HCC as a sign of dedifferentiation [12] . The loss is also seen in the context of increasing chromosomal instability [16, 17] . Deletion of 13q has been reported in other solid tumors, but with a frequency of less than 5% [18] . A recent study reported a loss of 13q occuring in CC [19] ; however, conventional CGH was used with a much lower resolution of approximately 1 MB. Moreover, the authors did not include which part of the chromosome arms were affected but only listed aberrations as a loss or gain of complete arms, which is not precise. As 13q deletion is reported as a sign of dedifferentiation, we wondered whether the CC cell lines not bearing this aberration were of low differentiation or not. We therefore conducted a histological examination, by placing tumor cells into a mouse model. This was done successfully for 2 cell lines. Both of them revealed a moderate differentiation after in vivo growth. We therefore assume that where there is not a loss of 13q, this is in the context of a preserved capability of tumor cells to differentiate, rather than it being a characteristic of cholangiolar differentiation.
Imbalances of chromosome 8 were also helpful in differentiating HCC cell lines from CC cell lines. A gain of 8q13-qter occurred in all CC cell lines. In HCC cell lines, a part of 8q was gained in 3 of 5 cell lines only. Interestingly in CC cell lines, the gain of 8q was accompanied by a loss of at least one copy of 8p in relation to 8q. This could be discussed as an isochromosome 8q [i(8q)]. This kind of aberration is the second most common isochromosome in human neoplasia and is frequently found in solid tumors such as adenocarcinoma (of the lung 22%, colon 15%, stomach 12%) and malignant melanoma (17%) [20] . It is frequently seen in acute myeloid leukemia and myelodysplastic syndrome and data on malignant melanoma also suggest it is a secondary rather than a primary aberration [20] . No data are available to suggest which of the aberrations, gain of 8q or loss of 8p has the greater effect on tumor progression. To date, gain of 8q seems to be the more important abnormality. This is not in full accordance with earlier reports demonstrating i(8q) in a large number of HCC cell lines and in correlation with a dedifferentiation and chromosomal instability [11] .
Loss of the short and gain of the long arm of a chromosome were also seen for chromosome 17. Indeed, this chromosome was the only one revealing the same aberration in all HCC and CC samples, i.e. gain of q21-qter. However, the regions spanned by this aberration were different, with HCC cell lines having a gain of 17q including the centromeric region and for some cases also parts of 17p. In CC cell lines, 17q+ was seen in varying extents with a common gained region starting at q21. Interestingly, in all CC cell lines, the gain of 17q was accompanied by a relative loss of 17p. We do not assume this finding to be an isochromosome i(17q), since the typical breaking region of i(17q) spans an interval of approximately 240 kB in the Smith-Magenis syndrome common deletion region in 17p11.2 [21] . Losses of 17p were not seen in HCC cell lines. Indeed, 4 of 5 cell lines revealed a gain of 17p interrupted by a not-gained region spanning from 17p12 to p13.2. For both cell lines, no loss of 13q was found and in both tumor samples a moderate (but not low) differentiation was seen.
Besides these aberrations occurring frequently in our cell lines and in surgical specimens, we found HCC cellline imbalances to be reported only rarely in the latter. These included gains of 11p, 12, 14q, 16p, 16q, 21q and 22q. Imbalances of these chromosomes are also rarely ( ! 10%) found to occur in other solid tumors with the exception of chromosomes 12 and 16; 12p is gained in tumors of the female and male genital tract [22] and 16q is altered by losses and not gains in lobular carcinoma and lobular carcinoma in situ [23, 24] . It is assumed that ECadherin is lost as a consequence of this aberration leading to the development of the lobular phenotype. Loss of 16q in such cases is frequently accompanied by a gain of 16p.
Taking these findings together, there are chromosomal imbalances found in surgical specimens of HCC/CC as well as in the cell lines. In part, these aberrations are typical for hepatic and/or cholangiolar differentiation. There are also imbalances detectable in cell lines probably necessary for ongoing tumor cell growth in vitro. These aberrations are found rarely in the surgical tumor specimens. However, it is not clear why they occur. It may be speculated that the imbalances could already be in the tumor cells from which the cell lines are derived, in which case it would have to be assumed that these aberrations are helpful for the tumor cells to maintain in vitro. On the other hand, these aberrations could occur as secondary events, giving a growth advantage for the tumor cells in vitro. The question which of these alternatives applies could only be answered by the culture of cloned cells obtained directly from surgical tumor specimens.
In conclusion, carcinoma cell lines of hepatic and cholangiolar origin can be separated by aberrations of chromosomes such as 1, 8 and 13. There are, nevertheless, aberrations shared by all cell lines such as 17q+. It will be of interest to investigate the implications of these aberrations in further detail.
